Indan Journal of Medical Research Indan Journal of Medical Research Indan Journal of Medical Research Indan Journal of Medical Research
  Home About us Editorial board Search Ahead of print Current issue Archives Submit article Instructions Subscribe Contacts Login  
  Home Print this page Email this page Small font sizeDefault font sizeIncrease font size Users Online: 492       

    Article Cited by others

ORIGINAL ARTICLE

Evaluation of epidermal growth factor receptor mutations based on mutation specific immunohistochemistry in non-small cell lung cancer: A preliminary study

Jain Deepali, Iqbal Sobuhi, Walia Ritika, Malik Prabhat, Cyriac Sunu, Mathur Sandeep R, Sharma Mehar C, Madan Karan, Mohan Anant, Bhalla Ashu, Pathy Sushmita, Kumar Lalit, Guleria Randeep

Year : 2016| Volume: 143| Issue : 3 | Page no: 308-314

   This article has been cited by
 
1 Epidermal growth factor receptor mutation status in pulmonary adenocarcinoma: Multi-institutional data discussion at national conference of “Lung Cancer Management in Indian context”
Tripti Nakra,Anurag Mehta,Amanjit Bal,Aruna Nambirajan,Deepak Mishra,Divya Midha,Nalini Gupta,Neeraj Arora,Parul Gupta,Pragya Gupta,Varsha Singh,Deepali Jain
Current Problems in Cancer. 2020; : 100561
[Pubmed]  [Google Scholar] [DOI]
2 EGFR mutations and ROS1 and ALK rearrangements in a large series of non-small cell cancer in South India
Anil Tarigopula,Gayathri Ramasubban,Vani Chandrashekar,Perumal Govindasami,Chitra Chandran
Cancer Reports. 2020;
[Pubmed]  [Google Scholar] [DOI]
3 Spectrum of uncommon and compound epidermal growth factor receptor mutations in non-small-cell lung carcinomas with treatment response and outcome analysis: A study from India
Varsha Singh,Aruna Nambirajan,Prabhat Singh Malik,Sanjay Thulkar,Ravindra Mohan Pandey,Kalpana Luthra,Sudheer Arava,Ruma Ray,Anant Mohan,Deepali Jain
Lung Cancer. 2020; 149: 53
[Pubmed]  [Google Scholar] [DOI]
4 Molecularly targeted therapies in non-small cell lung cancer: The evolving role of tyrosine kinase inhibitors
DC Doval,CJ Desai,TP Sahoo
Indian Journal of Cancer. 2019; 56(5): 23
[Pubmed]  [Google Scholar] [DOI]
5 Potential Molecular Signatures Predictive of Lung Cancer Brain Metastasis
Rute M. S. M. Pedrosa,Dana A. M. Mustafa,Joachim G. J. V. Aerts,Johan M. Kros
Frontiers in Oncology. 2018; 8
[Pubmed]  [Google Scholar] [DOI]
6 Adenocarcinoma predominant pattern subtyping and nuclear grading in cytology: Is there a role in prognostication of advanced pulmonary adenocarcinomas?
A. Nambirajan,H. Kaur,K. Jangra,K. Kaur,K. Madan,S. R. Mathur,V. K. Iyer,D. Jain
Cytopathology. 2018;
[Pubmed]  [Google Scholar] [DOI]
7 Epidermal growth factor receptor (EGFR), KRAS, and BRAF mutations in lung adenocarcinomas: A study from India
Varsha Singh,Prerna Guleria,Prabhat Singh Malik,Anant Mohan,Sanjay Thulkar,R M Pandey,Kalpana Luthra,Sudheer Arava,Ruma Ray,Deepali Jain
Current Problems in Cancer. 2018;
[Pubmed]  [Google Scholar] [DOI]
8 EGFR mutation status in Tunisian non-small-cell lung cancer patients evaluated by mutation-specific immunohistochemistry
Zohra Mraihi,Jihen Ben Amar,Hend Bouacha,Soumaya Rammeh,Lamia Hila
BMC Pulmonary Medicine. 2018; 18(1)
[Pubmed]  [Google Scholar] [DOI]

 

Read this article